[SCHEDULE 13G/A] Inozyme Pharma, Inc. SEC Filing
Inozyme Pharma, Inc. has a Schedule 13G/A filed on behalf of a reporting group that includes Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard and Kris Jenner. The filing identifies the reporting structure: Rock Springs Capital Management LP acts as investment manager, Rock Springs Capital LLC is the general partner, and Mark Bussard and Kris Jenner each own 50% of the management company.
The filing discloses an aggregate beneficial ownership of 0 shares, representing 0% of the class; sole and shared voting and dispositive powers are all reported as 0. Signatories certify the securities were not acquired to change or influence control, and a joint filing statement commits the parties to file amendments on behalf of all undersigned.
Inozyme Pharma, Inc. ha depositato uno Schedule 13G/A per conto di un gruppo dichiarante che include Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard e Kris Jenner. Il deposito specifica la struttura di segnalazione: Rock Springs Capital Management LP agisce come gestore degli investimenti, Rock Springs Capital LLC 猫 il general partner, e Mark Bussard e Kris Jenner possiedono ciascuno il 50% della societ脿 di gestione.
Il deposito dichiara una partecipazione economica aggregata di 0 azioni, pari al 0% della classe; i poteri di voto e di disposizione, sia esclusivi sia condivisi, sono riportati come 0. I firmatari attestano che i titoli non sono stati acquisiti al fine di modificare o influenzare il controllo, e una dichiarazione congiunta impegna le parti a presentare emendamenti per conto di tutti i sottoscritti.
Inozyme Pharma, Inc. present贸 un Schedule 13G/A en nombre de un grupo informante que incluye a Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard y Kris Jenner. La presentaci贸n identifica la estructura del informante: Rock Springs Capital Management LP act煤a como gestor de inversiones, Rock Springs Capital LLC es el socio general, y Mark Bussard y Kris Jenner poseen cada uno el 50% de la sociedad gestora.
La presentaci贸n revela una propiedad beneficiaria agregada de 0 acciones, que representan el 0% de la clase; los poderes de voto y de disposici贸n, tanto exclusivos como compartidos, se reportan como 0. Los firmantes certifican que los valores no se adquirieron para cambiar o influir en el control, y una declaraci贸n conjunta compromete a las partes a presentar enmiendas en nombre de todos los suscritos.
Inozyme Pharma, Inc.電� Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard 氚� Kris Jenner毳� 韽暔頃橂姅 氤搓碃 攴鸽９鞚� 雽�響滍晿鞐� Schedule 13G/A毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 氤搓碃 甑“臧� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟: Rock Springs Capital Management LP電� 韴瀽甏�毽殞靷靹� 鞐暊鞚� 頃橁碃, Rock Springs Capital LLC電� 鞚茧皹 韺岉姼雱堨澊氅�, Mark Bussard鞕� Kris Jenner電� 臧侁皝 甏�毽殞靷潣 50%毳� 靻岇湢頃橁碃 鞛堨姷雼堧嫟.
鞝滌稖靹滊姅 齑� 鞁れ 靻岇湢 欤检嫕鞚� 0欤�搿� 頃措嫻 韥措灅鞀れ潣 0%鞐� 頃措嫻頃潉 瓿店皽頃╇媹雼�; 雼弲 氚� 瓿惦彊鞚� 鞚橁舶甓岅臣 觳橂秳甓岇潃 氇憪 0鞙茧 氤搓碃霅橃棃鞀惦媹雼�. 靹滊獏鞛愲摛鞚� 頃措嫻 歃濌秾鞚� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 歃濍獏頃橂┌, 瓿惦彊 鞝滌稖 靹犾柛鞚� 氇摖 靹滊獏鞚胳潉 雽�鞁犿暣 靾橃爼靹滊ゼ 鞝滌稖頃� 瓴冹潉 鞎届啀頃╇媹雼�.
Inozyme Pharma, Inc. a d茅pos茅 un Schedule 13G/A au nom d'un groupe d茅clarant comprenant Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard et Kris Jenner. Le d茅p么t pr茅cise la structure de d茅claration : Rock Springs Capital Management LP agit en tant que gestionnaire d'investissement, Rock Springs Capital LLC est le commandit茅, et Mark Bussard et Kris Jenner d茅tiennent chacun 50% de la soci茅t茅 de gestion.
Le d茅p么t r茅v猫le une d茅tention b茅n茅ficiaire agr茅g茅e de 0 actions, repr茅sentant 0% de la cat茅gorie ; les pouvoirs de vote et de disposition, exclusifs comme partag茅s, sont tous indiqu茅s 脿 0. Les signataires certifient que les titres n'ont pas 茅t茅 acquis dans le but de modifier ou d'influencer le contr么le, et une d茅claration conjointe engage les parties 脿 d茅poser des amendements au nom de tous les soussign茅s.
Inozyme Pharma, Inc. hat ein Schedule 13G/A im Namen einer meldenden Gruppe eingereicht, zu der Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard und Kris Jenner geh枚ren. Die Einreichung beschreibt die Berichtstruktur: Rock Springs Capital Management LP fungiert als Investmentmanager, Rock Springs Capital LLC ist der Generalpartner, und Mark Bussard und Kris Jenner besitzen jeweils 50% der Managementgesellschaft.
Die Einreichung offenbart eine aggregierte wirtschaftliche Beteiligung von 0 Aktien, was 0% der Klasse entspricht; alleinige und gemeinsame Stimm- und Verf眉gungsmacht werden jeweils mit 0 angegeben. Die Unterzeichner bescheinigen, dass die Wertpapiere nicht erworben wurden, um die Kontrolle zu 盲ndern oder zu beeinflussen, und eine gemeinsame Erkl盲rung verpflichtet die Parteien, 脛nderungen im Namen aller Unterzeichnenden einzureichen.
- Explicit identification of reporting persons and their relationships, including investment manager and general partner roles.
- Clear disclosure that aggregate beneficial ownership is 0 shares (0%) and that voting and dispositive powers are reported as 0.
- Joint filing statement and certification commit the undersigned to file future amendments and attest to intent.
- No material holdings disclosed, so the filing contains no investor-impacting position.
- Four Pines Master Fund LP is referenced as holding shares in Item 2 but there is no separate reporting entry for Four Pines in the schedules provided.
Insights
TL;DR: The Rock Springs group reports no beneficial stake in INZY, so there is no immediate financial or control impact.
The filing documents the identities and relationships among fund entities and individuals but reports 0 shares and 0% ownership, with no voting or dispositive power. From a market-impact perspective, this disclosure is procedural and provides transparency about who would file future amendments, but it does not reflect an economic position that would affect valuation or control.
TL;DR: Joint filing and certification are in order; reported ownership and voting power are nil, so governance influence is absent.
The document clearly lists the reporting persons and their internal relationships, including the 50/50 ownership of the management company by Mark Bussard and Kris Jenner, and contains a joint filing agreement and certification stating no intent to influence control. Because the reported beneficial ownership and all voting/dispositive powers are 0, there is no change to issuer governance from these filings.
Inozyme Pharma, Inc. ha depositato uno Schedule 13G/A per conto di un gruppo dichiarante che include Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard e Kris Jenner. Il deposito specifica la struttura di segnalazione: Rock Springs Capital Management LP agisce come gestore degli investimenti, Rock Springs Capital LLC 猫 il general partner, e Mark Bussard e Kris Jenner possiedono ciascuno il 50% della societ脿 di gestione.
Il deposito dichiara una partecipazione economica aggregata di 0 azioni, pari al 0% della classe; i poteri di voto e di disposizione, sia esclusivi sia condivisi, sono riportati come 0. I firmatari attestano che i titoli non sono stati acquisiti al fine di modificare o influenzare il controllo, e una dichiarazione congiunta impegna le parti a presentare emendamenti per conto di tutti i sottoscritti.
Inozyme Pharma, Inc. present贸 un Schedule 13G/A en nombre de un grupo informante que incluye a Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard y Kris Jenner. La presentaci贸n identifica la estructura del informante: Rock Springs Capital Management LP act煤a como gestor de inversiones, Rock Springs Capital LLC es el socio general, y Mark Bussard y Kris Jenner poseen cada uno el 50% de la sociedad gestora.
La presentaci贸n revela una propiedad beneficiaria agregada de 0 acciones, que representan el 0% de la clase; los poderes de voto y de disposici贸n, tanto exclusivos como compartidos, se reportan como 0. Los firmantes certifican que los valores no se adquirieron para cambiar o influir en el control, y una declaraci贸n conjunta compromete a las partes a presentar enmiendas en nombre de todos los suscritos.
Inozyme Pharma, Inc.電� Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard 氚� Kris Jenner毳� 韽暔頃橂姅 氤搓碃 攴鸽９鞚� 雽�響滍晿鞐� Schedule 13G/A毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 氤搓碃 甑“臧� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟: Rock Springs Capital Management LP電� 韴瀽甏�毽殞靷靹� 鞐暊鞚� 頃橁碃, Rock Springs Capital LLC電� 鞚茧皹 韺岉姼雱堨澊氅�, Mark Bussard鞕� Kris Jenner電� 臧侁皝 甏�毽殞靷潣 50%毳� 靻岇湢頃橁碃 鞛堨姷雼堧嫟.
鞝滌稖靹滊姅 齑� 鞁れ 靻岇湢 欤检嫕鞚� 0欤�搿� 頃措嫻 韥措灅鞀れ潣 0%鞐� 頃措嫻頃潉 瓿店皽頃╇媹雼�; 雼弲 氚� 瓿惦彊鞚� 鞚橁舶甓岅臣 觳橂秳甓岇潃 氇憪 0鞙茧 氤搓碃霅橃棃鞀惦媹雼�. 靹滊獏鞛愲摛鞚� 頃措嫻 歃濌秾鞚� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 歃濍獏頃橂┌, 瓿惦彊 鞝滌稖 靹犾柛鞚� 氇摖 靹滊獏鞚胳潉 雽�鞁犿暣 靾橃爼靹滊ゼ 鞝滌稖頃� 瓴冹潉 鞎届啀頃╇媹雼�.
Inozyme Pharma, Inc. a d茅pos茅 un Schedule 13G/A au nom d'un groupe d茅clarant comprenant Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard et Kris Jenner. Le d茅p么t pr茅cise la structure de d茅claration : Rock Springs Capital Management LP agit en tant que gestionnaire d'investissement, Rock Springs Capital LLC est le commandit茅, et Mark Bussard et Kris Jenner d茅tiennent chacun 50% de la soci茅t茅 de gestion.
Le d茅p么t r茅v猫le une d茅tention b茅n茅ficiaire agr茅g茅e de 0 actions, repr茅sentant 0% de la cat茅gorie ; les pouvoirs de vote et de disposition, exclusifs comme partag茅s, sont tous indiqu茅s 脿 0. Les signataires certifient que les titres n'ont pas 茅t茅 acquis dans le but de modifier ou d'influencer le contr么le, et une d茅claration conjointe engage les parties 脿 d茅poser des amendements au nom de tous les soussign茅s.
Inozyme Pharma, Inc. hat ein Schedule 13G/A im Namen einer meldenden Gruppe eingereicht, zu der Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard und Kris Jenner geh枚ren. Die Einreichung beschreibt die Berichtstruktur: Rock Springs Capital Management LP fungiert als Investmentmanager, Rock Springs Capital LLC ist der Generalpartner, und Mark Bussard und Kris Jenner besitzen jeweils 50% der Managementgesellschaft.
Die Einreichung offenbart eine aggregierte wirtschaftliche Beteiligung von 0 Aktien, was 0% der Klasse entspricht; alleinige und gemeinsame Stimm- und Verf眉gungsmacht werden jeweils mit 0 angegeben. Die Unterzeichner bescheinigen, dass die Wertpapiere nicht erworben wurden, um die Kontrolle zu 盲ndern oder zu beeinflussen, und eine gemeinsame Erkl盲rung verpflichtet die Parteien, 脛nderungen im Namen aller Unterzeichnenden einzureichen.
FAQ
Who filed the Schedule 13G/A for Inozyme (INZY)?
How many Inozyme (INZY) shares do the reporting persons beneficially own?
Do the reporting persons have voting or dispositive power over INZY shares?
Do the filers state any intent to influence control of Inozyme (INZY)?
What ownership of the management company is disclosed?
